Ligand validation:4FGZ

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 4FGZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4FGZ_SAH_B_303	95%	27%	0.071	0.973	1.38	1.54	6	4	0	0	100%	1
4FGZ_SAH_A_303	92%	29%	0.072	0.961	1.33	1.5	5	2	0	0	100%	1
3UJB_SAH_B_502	95%	25%	0.07	0.974	1.24	1.77	4	4	0	0	100%	1
4R6W_SAH_B_302	93%	25%	0.073	0.969	1.39	1.63	6	6	0	0	100%	1
4R6X_SAH_A_502	74%	22%	0.126	0.956	1.51	1.75	6	5	1	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8QXQ_SAH_A_401	100%	51%	0.028	0.994	0.84	1.04	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.